HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased density of muscarinic receptors in the superior temporal gyrusin schizophrenia.

Abstract
Recent studies have indicated that muscarinic receptors are involved in the pathophysiology in schizophrenia, particularly in cognitive deficits. The superior temporal gyrus (STG) is an area that has also been strongly implicated in the pathophysiology of schizophrenia. Therefore, in this study, we investigated the binding density of two muscarinic antagonists, [(3)H]pirenzepine and [(3)H]AF-DX 384, in the STG of schizophrenia patients compared with controls. A significant decrease (44% in the superficial layers and 48% in the deep layers, P<0.01) in binding density of [(3)H]pirenzepine was observed in schizophrenia patients, which suggested a reduction of muscarinic M1 and M4 receptor densities in the STG of schizophrenia patients. A tendency toward decreased [(3)H]AF-DX 384 binding density (34%, P=0.09) was also observed in schizophrenia patients compared with controls. Because of the positive correlation between [(3)H]pirenzepine and [(3)H]AF-DX 384 binding, and, insofar as both ligands have high affinities for the M4 receptor, the involvement of M4 receptor alteration is also suggested in the STG in schizophrenia. These results suggest that changes of the muscarinic receptors M1 and M4 might contribute to the STG pathology in schizophrenia.
AuthorsChao Deng, Xu-Feng Huang
JournalJournal of neuroscience research (J Neurosci Res) Vol. 81 Issue 6 Pg. 883-90 (Sep 15 2005) ISSN: 0360-4012 [Print] United States
PMID16041805 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright(c) 2005 Wiley-Liss, Inc.
Chemical References
  • Muscarinic Antagonists
  • Receptor, Muscarinic M1
  • Receptor, Muscarinic M4
  • Receptors, Muscarinic
  • AFDX 384
  • Pirenzepine
Topics
  • Adult
  • Autoradiography
  • Female
  • Humans
  • Image Processing, Computer-Assisted
  • Male
  • Middle Aged
  • Muscarinic Antagonists (metabolism)
  • Pirenzepine (analogs & derivatives, metabolism)
  • Receptor, Muscarinic M1 (metabolism)
  • Receptor, Muscarinic M4 (metabolism)
  • Receptors, Muscarinic (metabolism)
  • Schizophrenia (metabolism, pathology)
  • Temporal Lobe (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: